logo
Share SHARE
FONT-SIZE Plus   Neg

MetroCorp Bancshares Q2 Profit Rises - Quick Facts

MetroCorp Bancshares Inc. (MCBI) reported that its second-quarter net income applicable to common stock was $2.8 million, compared to $2.5 million in the year-ago period. Earnings per share for the quarter was $0.15, down from $0.16 in the comparable quarter last year.

On average, three analysts polled by Thomson Reuters expected the company to earn $0.15 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the latest second quarter was $12.98 million, down 4.9% compared with $13.65 million in the year-ago period, while total non-interest income rose 10.5% to $1.9 million from $1.8 million in the prior year quarter.

The decrease in net interest income was primarily due to a decline in the yield on loans, partially offset by lower cost of deposits.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Coca-Cola Company (KO) reported a profit for the first-quarter of 2017 that declined 20 percent from the prior year. Net revenues declined 11%, reflecting unfavorable impacts from structural changes of 10% and foreign currency of 1%. The company remains on track to deliver its underlying revenue and profit targets for the full year. Eli Lilly and Co. (LLY) reported a loss for the first quarter of 2017 compared to profit in the prior year, primarily hurt by lower operating income, partially offset by higher other income. But, quarterly revenue increased 7 percent, driven by 9 percent pharmaceutical volume growth from Trulicity, Taltz and other new products. Capricor Therapeutics, Inc., a clinical-stage biotechnology company for cardiac and other medical conditions, announced Tuesday positive six-month results from the randomized phase I/II HOPE clinical trial in Duchenne muscular dystrophy or DMD. The HOPE clinical trial was designed to evaluate the safety and exploratory efficacy of CAP-1002.
comments powered by Disqus
Follow RTT